Mouse Akna Conditional Knockout Project (CRISPR/Cas9)

Total Page:16

File Type:pdf, Size:1020Kb

Mouse Akna Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Akna Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Akna conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Akna gene (NCBI Reference Sequence: NM_001045514 ; Ensembl: ENSMUSG00000039158 ) is located on Mouse chromosome 4. 22 exons are identified, with the ATG start codon in exon 2 and the TGA stop codon in exon 22 (Transcript: ENSMUST00000035724). Exon 3 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Akna gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-322B16 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a hypomorphic or a knock-out allele exhibit partial postnatal lethality, pathogen-induced acute neutrophil responses leading to systemic inflammation and alveolar destruction, and increased susceptibility to fungal infection. Exon 3 starts from about 5.98% of the coding region. The knockout of Exon 3 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 2240 bp, and the size of intron 3 for 3'-loxP site insertion: 2379 bp. The size of effective cKO region: ~1549 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 22 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Akna Homology arm cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. It may be difficult to construct this targeting vector. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(8049bp) | A(22.65% 1823) | C(26.24% 2112) | T(25.0% 2012) | G(26.12% 2102) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 7 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr4 - 63395885 63398884 3000 browser details YourSeq 99 2420 2566 3000 90.1% chr15 - 84327196 84327414 219 browser details YourSeq 88 2420 2652 3000 77.2% chr14 - 58138831 58139000 170 browser details YourSeq 86 2406 2565 3000 78.3% chr10 - 84463399 84463526 128 browser details YourSeq 81 2426 2565 3000 88.4% chr10 + 79641052 79641365 314 browser details YourSeq 80 2425 2563 3000 89.6% chr12 - 25478894 25479112 219 browser details YourSeq 76 2461 2585 3000 88.0% chr13 - 103756594 103756743 150 browser details YourSeq 75 2406 2648 3000 89.4% chr12 - 102383872 102384152 281 browser details YourSeq 70 2405 2565 3000 82.0% chr12 + 109142010 109142157 148 browser details YourSeq 69 2457 2565 3000 86.8% chr15 + 28039325 28039430 106 browser details YourSeq 68 2454 2565 3000 88.7% chr11 - 90455565 90455696 132 browser details YourSeq 68 2462 2568 3000 91.5% chr12 + 109062688 109062907 220 browser details YourSeq 67 2462 2587 3000 76.9% chr1 - 56801987 56802081 95 browser details YourSeq 67 2473 2644 3000 74.1% chr11 + 19398379 19398500 122 browser details YourSeq 66 2461 2565 3000 88.3% chr1 - 164539845 164540062 218 browser details YourSeq 64 2473 2565 3000 92.0% chr11 - 90315919 90316103 185 browser details YourSeq 64 2461 2565 3000 78.1% chr15 + 87581811 87581884 74 browser details YourSeq 63 2457 2565 3000 89.5% chr14 - 60668070 60668287 218 browser details YourSeq 56 2448 2565 3000 91.2% chr14 - 48306562 48306831 270 browser details YourSeq 55 2495 2568 3000 89.8% chr2 + 173396571 173396661 91 Note: The 3000 bp section upstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr4 - 63391336 63394335 3000 browser details YourSeq 110 985 1515 3000 91.8% chr15 - 84651971 84652803 833 browser details YourSeq 91 1018 1516 3000 74.8% chr1 - 86438439 86438779 341 browser details YourSeq 80 995 1223 3000 67.7% chrX - 10771483 10771712 230 browser details YourSeq 79 997 1223 3000 82.3% chr1 - 127867725 127867924 200 browser details YourSeq 77 1002 1221 3000 89.7% chr4 - 119186211 119186431 221 browser details YourSeq 76 1431 1528 3000 92.4% chr2 - 158455595 158650575 194981 browser details YourSeq 76 1425 1534 3000 84.6% chr1 - 66882958 66883067 110 browser details YourSeq 75 1385 1528 3000 85.1% chr2 - 166823308 166823442 135 browser details YourSeq 72 1035 1223 3000 89.2% chr7 - 134905299 134905487 189 browser details YourSeq 71 990 1220 3000 91.9% chr6 - 88217565 88218079 515 browser details YourSeq 71 1015 1221 3000 81.7% chr12 - 111174428 111174622 195 browser details YourSeq 71 981 1516 3000 72.7% chr1 + 6196961 6197252 292 browser details YourSeq 69 1000 1222 3000 92.6% chr1 + 86642191 86642603 413 browser details YourSeq 68 1384 1521 3000 78.8% chr7 + 126216399 126216534 136 browser details YourSeq 68 1422 1525 3000 82.7% chr6 + 146492076 146492179 104 browser details YourSeq 65 1424 1528 3000 89.4% chr2 - 173726716 173726818 103 browser details YourSeq 64 1429 1520 3000 90.0% chr1 - 192118355 192118447 93 browser details YourSeq 63 1002 1220 3000 93.2% chr4 - 86902752 86903645 894 browser details YourSeq 63 1384 1521 3000 86.5% chr1 - 36677930 36678066 137 Note: The 3000 bp section downstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. Page 4 of 7 https://www.alphaknockout.com Gene and protein information: Akna AT-hook transcription factor [ Mus musculus (house mouse) ] Gene ID: 100182, updated on 12-Aug-2019 Gene summary Official Symbol Akna provided by MGI Official Full Name AT-hook transcription factor provided by MGI Primary source MGI:MGI:2140340 See related Ensembl:ENSMUSG00000039158 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as AI597013 Expression Biased expression in spleen adult (RPKM 37.5), thymus adult (RPKM 21.8) and 13 other tissues See more Orthologs human all Genomic context Location: 4; 4 B3-C1 See Akna in Genome Data Viewer Exon count: 26 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 4 NC_000070.6 (63367123..63411094, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 4 NC_000070.5 (63028161..63064479, complement) Chromosome 4 - NC_000070.6 Page 5 of 7 https://www.alphaknockout.com Transcript information: This gene has 2 transcripts Gene: Akna ENSMUSG00000039158 Description AT-hook transcription factor [Source:MGI Symbol;Acc:MGI:2140340] Location Chromosome 4: 63,367,125-63,403,354 reverse strand. GRCm38:CM000997.2 About this gene This gene has 2 transcripts (splice variants), 151 orthologues, 1 paralogue, is a member of 1 Ensembl protein family and is associated with 8 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Akna-201 ENSMUST00000035724.4 5387 1404aa ENSMUSP00000041614.4 Protein coding CCDS38777 Q80VW7 TSL:5 GENCODE basic APPRIS P1 Akna-202 ENSMUST00000140586.1 707 No protein - lncRNA - - TSL:3 56.23 kb Forward strand 63.36Mb 63.37Mb 63.38Mb 63.39Mb 63.40Mb 63.41Mb Genes Orm3-201 >protein coding Aknaos-201 >lncRNA (Comprehensive set... Orm2-201 >protein coding Contigs AL683828.8 > Genes (Comprehensive set... < Akna-201protein coding < Akna-202lncRNA Regulatory Build 63.36Mb 63.37Mb 63.38Mb 63.39Mb 63.40Mb 63.41Mb Reverse strand 56.23 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding merged Ensembl/Havana Non-Protein Coding RNA gene Page 6 of 7 https://www.alphaknockout.com Transcript: ENSMUST00000035724 < Akna-201protein coding Reverse strand 36.23 kb ENSMUSP00000041... MobiDB lite Low complexity (Seg) Coiled-coils (Ncoils) Pfam Transcription factor, AT-hook-containing PANTHER Transcription factor, AT-hook-containing PTHR21510:SF15 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend inframe insertion inframe deletion missense variant synonymous variant Scale bar 0 200 400 600 800 1000 1200 1404 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 7 of 7.
Recommended publications
  • Analysis of Trans Esnps Infers Regulatory Network Architecture
    Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Anat Kreimer All rights reserved ABSTRACT Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer eSNPs are genetic variants associated with transcript expression levels. The characteristics of such variants highlight their importance and present a unique opportunity for studying gene regulation. eSNPs affect most genes and their cell type specificity can shed light on different processes that are activated in each cell. They can identify functional variants by connecting SNPs that are implicated in disease to a molecular mechanism. Examining eSNPs that are associated with distal genes can provide insights regarding the inference of regulatory networks but also presents challenges due to the high statistical burden of multiple testing. Such association studies allow: simultaneous investigation of many gene expression phenotypes without assuming any prior knowledge and identification of unknown regulators of gene expression while uncovering directionality. This thesis will focus on such distal eSNPs to map regulatory interactions between different loci and expose the architecture of the regulatory network defined by such interactions. We develop novel computational approaches and apply them to genetics-genomics data in human. We go beyond pairwise interactions to define network motifs, including regulatory modules and bi-fan structures, showing them to be prevalent in real data and exposing distinct attributes of such arrangements. We project eSNP associations onto a protein-protein interaction network to expose topological properties of eSNPs and their targets and highlight different modes of distal regulation.
    [Show full text]
  • Title a New Centrosomal Protein Regulates Neurogenesis By
    Title A new centrosomal protein regulates neurogenesis by microtubule organization Authors: Germán Camargo Ortega1-3†, Sven Falk1,2†, Pia A. Johansson1,2†, Elise Peyre4, Sanjeeb Kumar Sahu5, Loïc Broic4, Camino De Juan Romero6, Kalina Draganova1,2, Stanislav Vinopal7, Kaviya Chinnappa1‡, Anna Gavranovic1, Tugay Karakaya1, Juliane Merl-Pham8, Arie Geerlof9, Regina Feederle10,11, Wei Shao12,13, Song-Hai Shi12,13, Stefanie M. Hauck8, Frank Bradke7, Victor Borrell6, Vijay K. Tiwari§, Wieland B. Huttner14, Michaela Wilsch- Bräuninger14, Laurent Nguyen4 and Magdalena Götz1,2,11* Affiliations: 1. Institute of Stem Cell Research, Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany. 2. Physiological Genomics, Biomedical Center, Ludwig-Maximilian University Munich, Germany. 3. Graduate School of Systemic Neurosciences, Biocenter, Ludwig-Maximilian University Munich, Germany. 4. GIGA-Neurosciences, Molecular regulation of neurogenesis, University of Liège, Belgium 5. Institute of Molecular Biology (IMB), Mainz, Germany. 6. Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas and Universidad Miguel Hernández, Sant Joan d’Alacant, Spain. 7. Laboratory for Axon Growth and Regeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. 8. Research Unit Protein Science, Helmholtz Centre Munich, German Research Center for Environmental Health, Munich, Germany. 9. Protein Expression and Purification Facility, Institute of Structural Biology, Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany. 10. Institute for Diabetes and Obesity, Monoclonal Antibody Core Facility, Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany. 11. SYNERGY, Excellence Cluster of Systems Neurology, Biomedical Center, Ludwig- Maximilian University Munich, Germany. 12. Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, USA 13.
    [Show full text]
  • Genome-Wide Analysis of Host-Chromosome Binding Sites For
    Lu et al. Virology Journal 2010, 7:262 http://www.virologyj.com/content/7/1/262 RESEARCH Open Access Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Fang Lu1, Priyankara Wikramasinghe1, Julie Norseen1,2, Kevin Tsai1, Pu Wang1, Louise Showe1, Ramana V Davuluri1, Paul M Lieberman1* Abstract The Epstein-Barr Virus (EBV) Nuclear Antigen 1 (EBNA1) protein is required for the establishment of EBV latent infection in proliferating B-lymphocytes. EBNA1 is a multifunctional DNA-binding protein that stimulates DNA replication at the viral origin of plasmid replication (OriP), regulates transcription of viral and cellular genes, and tethers the viral episome to the cellular chromosome. EBNA1 also provides a survival function to B-lymphocytes, potentially through its ability to alter cellular gene expression. To better understand these various functions of EBNA1, we performed a genome-wide analysis of the viral and cellular DNA sites associated with EBNA1 protein in a latently infected Burkitt lymphoma B-cell line. Chromatin-immunoprecipitation (ChIP) combined with massively parallel deep-sequencing (ChIP-Seq) was used to identify cellular sites bound by EBNA1. Sites identified by ChIP- Seq were validated by conventional real-time PCR, and ChIP-Seq provided quantitative, high-resolution detection of the known EBNA1 binding sites on the EBV genome at OriP and Qp. We identified at least one cluster of unusually high-affinity EBNA1 binding sites on chromosome 11, between the divergent FAM55 D and FAM55B genes. A con- sensus for all cellular EBNA1 binding sites is distinct from those derived from the known viral binding sites, sug- gesting that some of these sites are indirectly bound by EBNA1.
    [Show full text]
  • Discovery of Genes Required for Body Axis and Limb Formation by Global Identification of Conserved Retinoic Acid Regulated Enhancers and Silencers
    bioRxiv preprint doi: https://doi.org/10.1101/778191; this version posted December 17, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Discovery of genes required for body axis and limb formation by global identification of conserved retinoic acid regulated enhancers and silencers Marie Berenguer1, Karolin F. Meyer1, Jun Yin2, and Gregg Duester1,* 1Development, Aging, and Regeneration Program 2Bioinformatics Core Facility Sanford Burnham Prebys Medical Discovery Institute, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA *Corresponding Author ([email protected]) Keywords: Body axis formation; retinoic acid signaling; enhancer; silencer; Aldh1a2 knockout; Nr2f1; Nr2f2 Short title: RNA-seq/ChIP-seq to find RA target genes 1 bioRxiv preprint doi: https://doi.org/10.1101/778191; this version posted December 17, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Identification of target genes for transcription factors is hampered by the large number of genes whose expression changes when the factor is removed from a specific tissue and the numerous binding sites for the factor in the genome. Retinoic acid (RA) regulates transcription via RA receptors bound to RA response elements (RAREs) of which there are thousands in vertebrate genomes. Here, we combined ChIP-seq and RNA-seq on trunk tissue from wild-type and Aldh1a2-/- embryos lacking RA synthesis that exhibit body axis and forelimb defects. We identified a relatively small number of genes with altered expression when RA is missing that also have nearby RA- regulated deposition of H3K27ac (gene activation mark) or H3K27me3 (gene repression mark) associated with conserved RAREs.
    [Show full text]
  • Myopia in African Americans Is Significantly Linked to Chromosome 7P15.2-14.2
    Genetics Myopia in African Americans Is Significantly Linked to Chromosome 7p15.2-14.2 Claire L. Simpson,1,2,* Anthony M. Musolf,2,* Roberto Y. Cordero,1 Jennifer B. Cordero,1 Laura Portas,2 Federico Murgia,2 Deyana D. Lewis,2 Candace D. Middlebrooks,2 Elise B. Ciner,3 Joan E. Bailey-Wilson,1,† and Dwight Stambolian4,† 1Department of Genetics, Genomics and Informatics and Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, United States 2Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland, United States 3The Pennsylvania College of Optometry at Salus University, Elkins Park, Pennsylvania, United States 4Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, United States Correspondence: Joan E. PURPOSE. The purpose of this study was to perform genetic linkage analysis and associ- Bailey-Wilson, NIH/NHGRI, 333 ation analysis on exome genotyping from highly aggregated African American families Cassell Drive, Suite 1200, Baltimore, with nonpathogenic myopia. African Americans are a particularly understudied popula- MD 21131, USA; tion with respect to myopia. [email protected]. METHODS. One hundred six African American families from the Philadelphia area with a CLS and AMM contributed equally to family history of myopia were genotyped using an Illumina ExomePlus array and merged this work and should be considered co-first authors. with previous microsatellite data. Myopia was initially measured in mean spherical equiv- JEB-W and DS contributed equally alent (MSE) and converted to a binary phenotype where individuals were identified as to this work and should be affected, unaffected, or unknown.
    [Show full text]
  • AKNA (NM 030767) Human Tagged ORF Clone – RC208832L3 | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC208832L3 AKNA (NM_030767) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: AKNA (NM_030767) Human Tagged ORF Clone Tag: Myc-DDK Symbol: AKNA Vector: pLenti-C-Myc-DDK-P2A-Puro (PS100092) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(RC208832). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_030767 ORF Size: 4317 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 AKNA (NM_030767) Human Tagged ORF Clone – RC208832L3 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_030767.2, NP_110394.2 RefSeq Size: 7387 bp RefSeq ORF: 4320 bp Locus ID: 80709 UniProt ID: Q7Z591, Q64FY1 MW: 155.1 kDa Gene Summary: Centrosomal protein that plays a key role in cell delamination by regulating microtubule organization (By similarity).
    [Show full text]
  • Potential Applications for Mrna and Peptide-Based Vaccines
    viruses Article An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines Guglielmo Lucchese 1,*,†, Hamid Reza Jahantigh 2,3,† , Leonarda De Benedictis 2, Piero Lovreglio 2 and Angela Stufano 2,3 1 Department of Neurology, Medical University of Greifswald, 17475 Greifswald, Germany 2 Interdisciplinary Department of Medicine-Section of Occupational Medicine, University of Bari, 70124 Bari, Italy; [email protected] (H.R.J.); [email protected] (L.D.B.); [email protected] (P.L.); [email protected] (A.S.) 3 Animal Health and Zoonosis Doctoral Program, Department of Veterinary Medicine, University of Bari, 70010 Bari, Italy * Correspondence: [email protected] † These authors contributed equally to the work. Abstract: Human T-cell lymphotropic virus type 1 (HTLV-1) infection affects millions of individuals worldwide and can lead to severe leukemia, myelopathy/tropical spastic paraparesis, and numerous other disorders. Pursuing a safe and effective immunotherapeutic approach, we compared the viral polyprotein and the human proteome with a sliding window approach in order to identify oligopeptide sequences unique to the virus. The immunological relevance of the viral unique oligopeptides was assessed by searching them in the immune epitope database (IEDB). We found that Citation: Lucchese, G.; Jahantigh, HTLV-1 has 15 peptide stretches each consisting of uniquely viral non-human pentapeptides which H.R.; De Benedictis, L.; Lovreglio, P.; Stufano, A. An Epitope Platform for are ideal candidate for a safe and effective anti-HTLV-1 vaccine. Indeed, experimentally validated Safe and Effective HTLV-1 epitopes, as retrieved from the IEDB, contain peptide sequences also present in a vast number HTLV-1-Immunization: Potential of human proteins, thus potentially instituting the basis for cross-reactions.
    [Show full text]
  • Bioinformatics Tools for the Analysis of Gene-Phenotype Relationships Coupled with a Next Generation Chip-Sequencing Data Processing Pipeline
    Bioinformatics Tools for the Analysis of Gene-Phenotype Relationships Coupled with a Next Generation ChIP-Sequencing Data Processing Pipeline Erinija Pranckeviciene Thesis submitted to the Faculty of Graduate and Postdoctoral Studies in partial fulfillment of the requirements for the Doctorate in Philosophy degree in Cellular and Molecular Medicine Department of Cellular and Molecular Medicine Faculty of Medicine University of Ottawa c Erinija Pranckeviciene, Ottawa, Canada, 2015 Abstract The rapidly advancing high-throughput and next generation sequencing technologies facilitate deeper insights into the molecular mechanisms underlying the expression of phenotypes in living organisms. Experimental data and scientific publications following this technological advance- ment have rapidly accumulated in public databases. Meaningful analysis of currently avail- able data in genomic databases requires sophisticated computational tools and algorithms, and presents considerable challenges to molecular biologists without specialized training in bioinfor- matics. To study their phenotype of interest molecular biologists must prioritize large lists of poorly characterized genes generated in high-throughput experiments. To date, prioritization tools have primarily been designed to work with phenotypes of human diseases as defined by the genes known to be associated with those diseases. There is therefore a need for more prioritiza- tion tools for phenotypes which are not related with diseases generally or diseases with which no genes have yet been associated in particular. Chromatin immunoprecipitation followed by next generation sequencing (ChIP-Seq) is a method of choice to study the gene regulation processes responsible for the expression of cellular phenotypes. Among publicly available computational pipelines for the processing of ChIP-Seq data, there is a lack of tools for the downstream analysis of composite motifs and preferred binding distances of the DNA binding proteins.
    [Show full text]
  • Genetic and Informatic Analyses Implicate Kif12 As a Candidate Gene Within the Mpkd2 Locus That Modulates Renal Cystic Disease Severity in the Cys1cpk Mouse
    Himmelfarb Health Sciences Library, The George Washington University Health Sciences Research Commons Pediatrics Faculty Publications Pediatrics 1-1-2015 Genetic and Informatic Analyses Implicate Kif12 as a Candidate Gene within the Mpkd2 Locus That Modulates Renal Cystic Disease Severity in the Cys1cpk Mouse. Michal Mrug Juling Zhou Chaozhe Yang Bruce J Aronow Xiangqin Cui See next page for additional authors Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs Part of the Pediatrics Commons Recommended Citation Mrug, M., Zhou, J., Yang, C., Aronow, B. J., Cui, X., Schoeb, T. R., … Guay-Woodford, L. M. (2015). Genetic and Informatic Analyses Implicate Kif12 as a Candidate Gene within the Mpkd2 Locus That Modulates Renal Cystic Disease Severity in the Cys1cpk Mouse. PLoS ONE, 10(8), e0135678. http://doi.org/10.1371/journal.pone.0135678 This Journal Article is brought to you for free and open access by the Pediatrics at Health Sciences Research Commons. It has been accepted for inclusion in Pediatrics Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please contact [email protected]. Authors Michal Mrug, Juling Zhou, Chaozhe Yang, Bruce J Aronow, Xiangqin Cui, Trenton R Schoeb, Gene P Siegal, Bradley K Yoder, and Lisa M. Guay-Woodford This journal article is available at Health Sciences Research Commons: https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/1445 RESEARCH ARTICLE Genetic and Informatic Analyses Implicate Kif12 as a Candidate Gene within the Mpkd2 Locus That Modulates Renal Cystic Disease Severity in the Cys1cpk Mouse Michal Mrug1,7*, Juling Zhou1, Chaozhe Yang2,8, Bruce J.
    [Show full text]
  • AKNA Frameshift Variant in Three Dogs with Recurrent Inflammatory Pulmonary Disease
    G C A T T A C G G C A T genes Article AKNA Frameshift Variant in Three Dogs with Recurrent Inflammatory Pulmonary Disease 1, 1, 2 1 Petra Hug y, Linda Anderegg y, Alexandra Kehl , Vidhya Jagannathan and Tosso Leeb 1,* 1 Institute of Genetics, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland 2 Laboklin, 97688 Bad Kissingen, Germany * Correspondence: [email protected]; Tel.: +41-31-631-23-26 These two authors contributed equally to this paper. y Received: 26 June 2019; Accepted: 25 July 2019; Published: 26 July 2019 Abstract: We investigated three related Rough Collies with recurrent inflammatory pulmonary disease. The clinical symptoms were similar to primary ciliary dyskinesia (PCD). However, the affected dogs did not carry any known pathogenic PCD variants. Pedigree analysis suggested a recessive mode of inheritance. Combined linkage and homozygosity mapping in three cases and seven non-affected family members delineated 19 critical intervals on 10 chromosomes comprising a total of 99 Mb. The genome of one affected dog was sequenced and compared to 601 control genomes. We detected only a single private homozygous protein-changing variant in the critical intervals. The detected variant was a 4 bp deletion, c.2717_2720delACAG, in the AKNA gene encoding the AT-hook transcription factor. It causes a frame-shift introducing a premature stop codon and truncates 37% of the open reading frame, p.(Asp906Alafs*173). We genotyped 88 Rough Collies consisting of family members and unrelated individuals. All three available cases were homozygous for the mutant allele and all 85 non-affected dogs were either homozygous wildtype (n = 67) or heterozygous (n = 18).
    [Show full text]
  • Downloaded Per Proteome Cohort Via the Web- Site Links of Table 1, Also Providing Information on the Deposited Spectral Datasets
    www.nature.com/scientificreports OPEN Assessment of a complete and classifed platelet proteome from genome‑wide transcripts of human platelets and megakaryocytes covering platelet functions Jingnan Huang1,2*, Frauke Swieringa1,2,9, Fiorella A. Solari2,9, Isabella Provenzale1, Luigi Grassi3, Ilaria De Simone1, Constance C. F. M. J. Baaten1,4, Rachel Cavill5, Albert Sickmann2,6,7,9, Mattia Frontini3,8,9 & Johan W. M. Heemskerk1,9* Novel platelet and megakaryocyte transcriptome analysis allows prediction of the full or theoretical proteome of a representative human platelet. Here, we integrated the established platelet proteomes from six cohorts of healthy subjects, encompassing 5.2 k proteins, with two novel genome‑wide transcriptomes (57.8 k mRNAs). For 14.8 k protein‑coding transcripts, we assigned the proteins to 21 UniProt‑based classes, based on their preferential intracellular localization and presumed function. This classifed transcriptome‑proteome profle of platelets revealed: (i) Absence of 37.2 k genome‑ wide transcripts. (ii) High quantitative similarity of platelet and megakaryocyte transcriptomes (R = 0.75) for 14.8 k protein‑coding genes, but not for 3.8 k RNA genes or 1.9 k pseudogenes (R = 0.43–0.54), suggesting redistribution of mRNAs upon platelet shedding from megakaryocytes. (iii) Copy numbers of 3.5 k proteins that were restricted in size by the corresponding transcript levels (iv) Near complete coverage of identifed proteins in the relevant transcriptome (log2fpkm > 0.20) except for plasma‑derived secretory proteins, pointing to adhesion and uptake of such proteins. (v) Underrepresentation in the identifed proteome of nuclear‑related, membrane and signaling proteins, as well proteins with low‑level transcripts.
    [Show full text]
  • Comprehensive Analysis of Transcription Factors Identified
    Journal of Cancer 2021, Vol. 12 5605 Ivyspring International Publisher Journal of Cancer 2021; 12(18): 5605-5621. doi: 10.7150/jca.58484 Research Paper Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancer Yihao Liao1#; Xuanxuan Zou2#; Keke Wang1#; Youzhi Wang1; Miaomiao Wang1; Tao Guo1; Boqiang Zhong1; 1 Ning Jiang 1. Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China. 2. College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China. # Yihao Liao, Xuanxuan Zou and Keke Wang contributed equally. Corresponding author: Ning Jiang. Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. Email: [email protected]; Tel: +86 02288329296 © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2021.01.21; Accepted: 2021.07.20; Published: 2021.07.25 Abstract Background: Transcriptional factors (TFs) are responsible for regulating the transcription of pro-oncogenes and tumor suppressor genes in the process of tumor development. However, the role of these transcription factors in Bladder cancer (BCa) remains unclear. And the main purpose of this research is to explore the possibility of these TFs serving as biomarkers for BCa. Methods: We analyzed the differential expression of TFs in BCa from The Cancer Genome Atlas (TCGA) online database, identified 408 up-regulated TFs and 751down-regulated TFs. We obtained some hub genes via WGCNA model and detected the RNAs level in BCa cells and tissues.
    [Show full text]